Clinical Trials in Nashville

Showing 1781-1800 of 9,711 trials

Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis

NCT06747858

ARCT-032-02 is a Phase 2, open-label, multicenter, multiple-ascending dose study of ARCT-032 in adults with CF who are not eligible for CFTR modulator therapy or are not taking CFTR modulators due to drug intolerance, poor response, or lack of access to modulators.

Cystic FibrosisCFTR Gene Mutation

Arcturus Therapeutics, Inc.12 participantsStarted Dec 2024

Tucson, Arizona, United States • Little Rock, Arkansas, United States • Los Angeles, California, United States +8 more locations

RECRUITINGPhase 1< 1 mile

A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects With Advanced Solid Tumors

NCT06403436

The purpose of this study is to test the safety and therapeutic effect of TT125-802 (single agent) in subjects with advanced solid tumors.

Advanced Solid TumorAdult Solid TumorAdult Disease+5 more

TOLREMO therapeutics AG50 participantsStarted Nov 2023

Nashville, Tennessee, United States • Fairfax, Virginia, United States • Barcelona, Spain +4 more locations

Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis

A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects With Advanced Solid Tumors

Find Trials by Condition in Nashville

Aviptadil for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)

Study of ARO-HIF2 in Patients With Advanced Clear Cell Renal Cell Carcinoma

Sleep Actigraphy in Postural Tachycardia Syndrome (POTS)

High vs. Standard Dose Influenza Vaccines in Lung Transplant (Repeater)

Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study)

Frespaciguat (MK-5475) INSIGNIA-PH-COPD: A Study of the Efficacy and Safety of Frespaciguat (an Inhaled sGC Stimulator) in Adults With PH-COPD

Clinical Performance of Two Frequent Replacement Silicone Hydrogel Multifocal Contact Lenses

A Study of Safety and Efficacy of Tildacerfont in Females With Polycystic Ovary Syndrome and Elevated Adrenal Androgens

A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies

Clinical Decision Support for PrEP

Optilume PoST AppRoval Clinical Evaluation of Andrology ParaMeters

A Study of Subcutaneous Nivolumab Versus Intravenous Nivolumab in Participants With Previously Treated Clear Cell Renal Cell Carcinoma That is Advanced or Has Spread

A Clinical Trial of CAP-003 Gene Therapy in Adult Patients With GBA1 Associated Parkinson's Disease

Safety and Efficacy Trial of MTX101 2mg for the Acute Treatment of Migraine in Adults

Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease

Kaneka Endovascular Embolization and Protection

A Phase 2 Multicenter Study of High Dose Chemotherapy With Autologous Stem Cell Transplant Followed by Maintenance Therapy With Romidepsin for the Treatment of T Cell Non-Hodgkin Lymphoma

Safety Study of Zinc Finger Nuclease CCR5-modified Hematopoietic Stem/Progenitor Cells in HIV-1 Infected Patients